These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9777790)

  • 41. Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.
    van Lingen RG; Poll MK; Seyger MM; de Jong EM; van de Kerkhof PC; van Erp PE
    Arch Dermatol Res; 2008 Nov; 300(10):561-7. PubMed ID: 18496701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of etanercept on the expression of markers of T helper 17 cells and their precursors in skin lesions of patients with psoriasis vulgaris.
    Antiga E; Volpi W; Chiarini C; Cardilicchia E; Filì L; Manuelli C; Parrochi P; Fabbri P; Caproni M
    Int J Immunopathol Pharmacol; 2010; 23(3):767-74. PubMed ID: 20943046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination treatment of psoriasis with photochemotherapy and tazarotene gel, a receptor-selective topical retinoid.
    Behrens S; Grundmann-Kollmann M; Peter RU; Kerscher M
    Br J Dermatol; 1999 Jul; 141(1):177. PubMed ID: 10417841
    [No Abstract]   [Full Text] [Related]  

  • 44. Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study.
    Bowman PH; Maloney JE; Koo JY
    J Am Acad Dermatol; 2002 Jun; 46(6):907-13. PubMed ID: 12063489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin.
    Kuijpers AL; Van Pelt JP; Bergers M; Boegheim PJ; Den Bakker JE; Siegenthaler G; Van de Kerkhof PC; Schalkwijk J
    Br J Dermatol; 1998 Sep; 139(3):380-9. PubMed ID: 9988537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin.
    Machtinger LA; Kaidbey K; Lim J; Loven KH; Rist TE; Wilson DC; Parizadeh DD; Sefton J; Holland JM; Walker PS
    Br J Dermatol; 2004 Dec; 151(6):1245-52. PubMed ID: 15606521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tazarotene Revisited: Safety and Efficacy in Plaque Psoriasis and Its Emerging Role in Treatment Strategy.
    Tanghetti E; Lebwohl M; Stein Gold L
    J Drugs Dermatol; 2018 Dec; 17(12):1280-1287. PubMed ID: 30586259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.
    Albanesi C; De Pità O; Girolomoni G
    Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro compatibility of tazarotene with other topical treatments of psoriasis.
    Hecker D; Worsley J; Yueh G; Lebwohl M
    J Am Acad Dermatol; 2000 Jun; 42(6):1008-11. PubMed ID: 10827404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genital ulcers in a psoriasis patient using topical tazarotene.
    Wollina U
    Br J Dermatol; 1998 Apr; 138(4):713-4. PubMed ID: 9640392
    [No Abstract]   [Full Text] [Related]  

  • 51. New treatment options for psoriasis.
    McClelland PB
    Dermatol Nurs; 1997 Oct; 9(5):295-304; quiz 305-6. PubMed ID: 9392761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered.
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Invest Dermatol; 2004 Jan; 122(1):51-60. PubMed ID: 14962089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-217 is down-regulated in psoriasis and promotes keratinocyte differentiation via targeting GRHL2.
    Zhu H; Hou L; Liu J; Li Z
    Biochem Biophys Res Commun; 2016 Feb; 471(1):169-76. PubMed ID: 26826389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased expression of CD208 (DC-LAMP) in epidermal keratinocytes of psoriatic lesions.
    Higaki M; Higaki Y; Kawashima M
    J Dermatol; 2009 Mar; 36(3):144-9. PubMed ID: 19335688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis.
    Wu NL; Huang DY; Hsieh SL; Hsiao CH; Lee TA; Lin WW
    Biochim Biophys Acta; 2013 Oct; 1832(10):1538-48. PubMed ID: 23707413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy.
    Pariser DM; Green LJ; Stein Gold L; Sugarman JL; Lin T; Pillai R
    J Drugs Dermatol; 2018 Jul; 17(7):723-726. PubMed ID: 30005093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque Psoriasis.
    Stein Gold L; Bagel J; Lebwohl M; Lin T; Martin G; Pillai R
    J Drugs Dermatol; 2018 Dec; 17(12):1290-1296. PubMed ID: 30586261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-194 regulates keratinocyte proliferation and differentiation by targeting Grainyhead-like 2 in psoriasis.
    Yu X; An J; Hua Y; Li Z; Yan N; Fan W; Su C
    Pathol Res Pract; 2017 Feb; 213(2):89-97. PubMed ID: 28040329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel.
    Behrens S; Grundmann-Kollmann M; Schiener R; Peter RU; Kerscher M
    J Am Acad Dermatol; 2000 Mar; 42(3):493-5. PubMed ID: 10688723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
    Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
    PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.